Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

NCT03153137 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Heart Disease

Interventions

DRUG: Macitentan 10 mg
DRUG: Placebo

Sponsor

Actelion